The influence of lysophosphatidic acid on the functions of human dendritic cells

Journal of Immunology

Volumn 169, Issue 8, 2002, Pages 4129-4135

  Panther, Elisabeth ^a   Idzko, Marco ^a   Corinti, Silvia ^a   Ferrari, Davide ^a   Herouy, Yared ^a   Mockenhaupt, Maja ^a   Dichmann, Stefan ^a   Gebicke Haerter, Peter ^a   Di Virgilio, Francesco ^a   Girolomoni, Giampiero ^a   Norgauer, Johannes ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 10; INTERLEUKIN 12; LYSOPHOSPHATIDIC ACID; PERTUSSIS TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACTIN POLYMERIZATION; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL KINETICS; CELL MATURATION; CELL MIGRATION; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; ENDOTHELIAL DIFFERENTIATION GENE 2; ENDOTHELIAL DIFFERENTIATION GENE 4; ENDOTHELIAL DIFFERENTIATION GENE 7; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRANSPORT KINETICS;

EID: 0037108348     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.8.4129     Document Type: Article

References (38)

1. Moolenar, W. H. 2000. Development of our current understanding of bioactive lysophospholipids. Ann. NY Acad. Sci. 905:1.
2. Moolenaar, W. H. 1999. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253:230.
3. 2 protein interaction. J. Clin. Invest. 102:1152.
4. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919.
5. Eichholtz, T., K. Jalink, I. Fahrenfort, and W. H. Moolenaar. 1993. The bioactive phopholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:677.
6. Gaits, F., O. Fourcade, F. LeBalle, G. Gueguen, B. Gaige, A. Gassama-Diage, J. Fauvel, J. P. Salles, G. Mauco, M. F. Simon, and H. Chap. 1997. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis, FEBS Lett. 410:54.
7. Siess, W., K. J. Zangl, M. Essler, M. Bauer, R. Brandl, C. Corrinth, R. Bittman, G. Tigyi, and M. Aepfelbacher. 1999. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Proc. Acad. Sci. USA 96:6931.
8. Goetzl, E., and K. Lynch. 2000. Preface: the omnific lysophospholipid growth factors. Ann. NY Acad. Sci. 905:X1.
9. Kumagai, N., C. N. Inoue, Y. Kondo, and K. Iinuma. 2000. Mitogenic action of lysophosphatidic acid in proximal tubular epithelial cells obtained from voided human urine. Clin. Sci. 99:561.
10. Balazs, L., J. Okolicany, M. Ferrebee, B. Tolley, and G. Tigyi. 2001. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am. J. Physiol. 280:R466.
11. Piazza, G. A., J. L. Ritter, and C. A. Baracka. 1995. Lysophosphatidic acid induction of transforming growth factors α and β: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216:51.
12. Toews, M. L., E. E. Ustinova, and H. D. Schultz, 1997. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle. J. Appl. Physiol. 83: 1216.
13. Panetti, T. C., and D. F. Mosher. 2000. Lysophopholipid-induced cell migration. Ann. NY Acad. Sci. 905:326.
14. Xu, Y., Y. J. Xiao, L. M. Baudhuin, and B. M. Schwartz. 2001. The role and clinical applications of bioactive lysolipids in ovarian cancer. J. Soc. Gynecol. Investig. 8:1.
15. Retzer, M., and M. Essler, 2000. Lysophosphatidic acid-induced platelet shape change proceeds via Rho/Rho kinase-mediated myosin light chain and moesin phosphorylation. Cell. Signal. 12:645.
16. Zheng, Y., J. Voice, Y. Kong, and E. J. Goetzl. 2000. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J. 14:2387.
17. Goetzl, E. J., Y. Kong, and J. K. Voice. 2000. Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J. Immunol. 16:4996.
18. Zheng, Y., Y. Kong, and E. J. Goetzl. 2001. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a matrigel model basement membrane. J. Immunol. 166:2317.
19. Rosskopf, D., W. Daelman, S. Busch, M. Schürks, K. Hartung, A. Kribben, M. C. Michel, and W. Siefert. 1998. Growth factor-like action of lysophosphatidic acid on human B lymphoblasts. Am. J. Physiol. 274:C1573.
20. Rizza, C., N. Leitinger, J. Yue, D. J. Fischer, D. A. Wang, P. T. Shih, H. Lee, G. Tigyi, and J. A. Berliner. 1999. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79:1227.
21. Contos, J. J., I. Ishii, and J. Chun. 2000. Lysophosphatidic acid receptors. Mol. Pharmacol. 58:1188.
22. Swarthout, J. T., and H. W. Walling. 2000. Lysophosphatidic acid: receptors, signaling and survival. Cell. Mol. Life Sci. 57:1978.
23. Ishii, I., J. J. Contos, N. Fukushima, and J. Chun. 2000. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-I/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58:895.
24. αi protein. J. Neurochem. 75:1575.
25. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
26. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92.
27. Gallucci, S., and P. Matzinger. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13:114.
28. Sozzani, S., P. Allavena, A. Vecchi, and A. Mantovani. 2000. Chemokines and dendritic cell traffic. J. Clin. Immunol. 20:151.
29. Idzko, M., E. Panther, S. Corinti, A. Morelli, D. Ferrari, Y. Herouy, S. Dichmann, M. Mockenhaupt, P. Gebicke-Haerter, F. Di Virgilio, et al. 2002. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature dendritic cells for emergence of Th2 immune responses. FASEB J. 16: 625.
30. 2 protein interaction J. Clin. Invest. 102:1152.
31. 2 and arachidonate increase in bronchoalveolar lavage fluid inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 155:421.
32. Stadel, J. M., K. Hoyle, R. M. Nacerio, A. Roshak, and F. H. Chilton. 1994. Characterisation of phospholipase A2 from human nasal lavage. Am. J. Respir. Cell Mol. Biol. 11:108.
33. Chilton, F. H., F. J. Averill, W. C. Hubbard, A. N. Fonteh, M. Triggiani, and M. C. Liu. 1996. Antigen-induced generation of lyso-phospholipids in human airways. J. Exp. Med. 183:2235.
34. Panther, E., M. Idzko, Y. Herouy, H. Rheinen, P. J. Gebicke-Haerter, U. Mrowietz, S. Dichmann, and J. Norgauer. 2001. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15:1963.
35. Dichmann, S., H. Rheinen, E. Panther, Y. Herouy, W. Czech, C. Termeer, J. C. Simon, P. J. Gebicke-Haerter, and J. Norgauer. 2000. Downregulation of platelet activating factor responsiveness during maturation of human dendritic cells. J. Cell. Physiol. 185:394.
36. s contains an unidentified covalent modification that increases its affinity for adenylyl cyclase. Proc. Natl. Acad. Sci USA 94:6116.
37. Kleuss, C., J. Hescheler, C. Ewel, W. Rosenthal, G. Schultz, and B. Wittig. 1991. Assignment of G protein subunits to specific receptors inducing inhibition of calcium currents. Nature 353:43.
38. Siffert, W., D. Rosskopf, G. Siffert, S. Busch, A. Moritz, R. Erbe, A. M. Sharma, E. Ritz, H. E. Wichmann, K. H. Jakobs, and B. Horsthemke. 1998. Association of a human G protein β3 subunit variant with hypertension. Nat. Genet. 18:45.